Genetics and Neurosciences

New pharmacological target for Fragile X Syndrome and related disorders
New therapeutic target for Fragile X Syndrome and related disorders based on an antagonist of the cannabinoid receptor CB1 for use in the prevention/treatment of diseases with neuronal dendritic...
The Research Group on Developmental Biology is led by Dr. Fernando Giraldez, Dra. Cristina Pujades and Dra. Berta Alsina. The group focuses on the study of cellular and molecular mechanisms that...
The Research Group on Genetics is led by Dr. Luis Pérez Jurado. The group focuses on genetics of cognitive functions, with an special emphasis in two pathologies, Williams-Beuren Syndrome and Autism...
The Research Group on NeuroPharmacology is led by Dr. Rafael Maldonado. The group focuses on the neurobiological substrate of drug addiction, pain, affective and eating disorders, with a main...
The Research Group on NeuroPsycoPharmacology is a joint research group of IMIM-Hospital del Mar Research Institute and Universitat Pompeu Fabra (UPF) led by Dr. Rafael de la Torre. The group  focuses...
Their goal is to offer high added value products and services to geneticists and clinicians, patients and their families. Services that are structured around the interpretation, in a clinical context...
An add-on drug for preventing adverse effects (anxiety disorders) of cannabinoid therapies without altering the analgesic and anxiolytic beneficial effects of THC. Main advantages of this technology...
Subscribe to Genetics and Neurosciences